Cary Street Partners Investment Advisory LLC Abb Vie Inc. Transaction History
Cary Street Partners Investment Advisory LLC
- $2.63 Billion
- Q3 2024
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 129,870 shares of ABBV stock, worth $26 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
129,870
Previous 125,918
3.14%
Holding current value
$26 Million
Previous $21.6 Million
18.75%
% of portfolio
0.97%
Previous 0.89%
Shares
22 transactions
Others Institutions Holding ABBV
# of Institutions
3,785Shares Held
1.28BCall Options Held
13MPut Options Held
9.82M-
Vanguard Group Inc Valley Forge, PA171MShares$34.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.6 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.7 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.74 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $355B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...